Clinical trial
Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy…
NCT00294047 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00294047 |
|---|---|
| Title | Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older |
| Official title | A Study to Evaluate Safety, Immunogenicity and Efficacy of GSK Biologicals HPV-16/18 L1/AS04 Vaccine Administered Intramuscularly According to a Three-dose Schedule (0, 1, 6 Month) in Healthy Adult Female Subjects Aged 26 Years and Above |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infections, Papillomavirus, Papillomavirus Vaccines |
| Intervention type | Biological |
| Interventions | Cervarix, Placebo control |
| Enrollment | 5,752 |
| Start date | Feb 16, 2006 |
| Primary completion | Jan 29, 2014 |
| Completion | Jan 29, 2014 |
| First posted | Feb 20, 2006 |
| Last update posted | Jan 2, 2020 |
| Countries | Australia, Canada, Mexico, Netherlands, Peru, Philippines, Portugal, Russia, Singapore, Thailand, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: